Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Survey of Radon Testing and Mitigation by Wisconsin Residents, Landlords, and School Districts.

Denu RA, Maloney J, Tomasallo CD, Jacobs NM, Krebsbach JK, Schmaling AL, Perez E, Bersch AJ, LeCaire TJ, Meiman JG, Malecki KM, LoConte NK.

WMJ. 2019 Dec;118(4):169-176.

2.

Association of Immune Thrombocytopenia and T-Lymphoblastic Lymphoma in a Pediatric Patient.

Denu RA, Matson DR, Davis MJ, Tedford NJ, Brichta CE, Diamond CA, Hoover-Regan ML.

Case Rep Hematol. 2019 Dec 17;2019:1425151. doi: 10.1155/2019/1425151. eCollection 2019.

3.

Centrosome Amplification in Cancer Disrupts Autophagy and Sensitizes to Autophagy Inhibition.

Denu RA, Kaur G, Sass MM, Lakkaraju A, Burkard ME.

Mol Cancer Res. 2020 Jan;18(1):33-45. doi: 10.1158/1541-7786.MCR-19-0509. Epub 2019 Oct 11.

PMID:
31604847
4.

Polo-like kinase 4 maintains centriolar satellite integrity by phosphorylation of centrosomal protein 131 (CEP131).

Denu RA, Sass MM, Johnson JM, Potts GK, Choudhary A, Coon JJ, Burkard ME.

J Biol Chem. 2019 Apr 19;294(16):6531-6549. doi: 10.1074/jbc.RA118.004867. Epub 2019 Feb 25.

PMID:
30804208
5.

Reported Biologic Differences in Breast Cancer by Race Due to Disparities in Screening.

Denu RA.

JAMA Oncol. 2018 Jun 1;4(6):883. doi: 10.1001/jamaoncol.2017.5906. No abstract available.

6.

Centriole Overduplication is the Predominant Mechanism Leading to Centrosome Amplification in Melanoma.

Denu RA, Shabbir M, Nihal M, Singh CK, Longley BJ, Burkard ME, Ahmad N.

Mol Cancer Res. 2018 Mar;16(3):517-527. doi: 10.1158/1541-7786.MCR-17-0197. Epub 2018 Jan 12.

7.

Familial Trigeminal Neuralgia Treated with Stereotactic Radiosurgery: A Case Report and Literature Review.

Denu RA, Rosenberg SA, Howard SP.

J Radiat Oncol. 2017 Jun;6(2):149-152. doi: 10.1007/s13566-017-0300-0. Epub 2017 Mar 20.

8.

Potential yield of imminent death kidney donation.

Denu RA, Mendonca EA, Fost N.

Am J Transplant. 2018 Feb;18(2):486-491. doi: 10.1111/ajt.14524. Epub 2017 Nov 11.

9.

Racial and Socioeconomic Disparities Are More Pronounced in Inflammatory Breast Cancer Than Other Breast Cancers.

Denu RA, Hampton JM, Currey A, Anderson RT, Cress RD, Fleming ST, Lipscomb J, Wu XC, Wilson JF, Trentham-Dietz A.

J Cancer Epidemiol. 2017;2017:7574946. doi: 10.1155/2017/7574946. Epub 2017 Aug 15.

10.

SIRT3 Enhances Mesenchymal Stem Cell Longevity and Differentiation.

Denu RA.

Oxid Med Cell Longev. 2017;2017:5841716. doi: 10.1155/2017/5841716. Epub 2017 Jun 21.

11.

Estimates of Cancer Deaths Prevented by Raising Cigarette Taxes.

Denu RA.

JAMA Intern Med. 2017 May 1;177(5):739. doi: 10.1001/jamainternmed.2017.0327. No abstract available.

PMID:
28460094
12.

Synchronous Bilateral Breast Cancer in a Patient With Nager Syndrome.

Denu RA, Burkard ME.

Clin Breast Cancer. 2017 Jun;17(3):e151-e153. doi: 10.1016/j.clbc.2016.12.009. Epub 2017 Jan 5. No abstract available.

13.

Effects of Oxidative Stress on Mesenchymal Stem Cell Biology.

Denu RA, Hematti P.

Oxid Med Cell Longev. 2016;2016:2989076. doi: 10.1155/2016/2989076. Epub 2016 Jun 16. Review.

14.

Fibroblasts and Mesenchymal Stromal/Stem Cells Are Phenotypically Indistinguishable.

Denu RA, Nemcek S, Bloom DD, Goodrich AD, Kim J, Mosher DF, Hematti P.

Acta Haematol. 2016;136(2):85-97. doi: 10.1159/000445096. Epub 2016 May 18.

15.

Management of differentiation syndrome in an elderly patient with acute promyelocytic leukemia who subsequently developed refractory anemia with ring sideroblasts.

Denu RA, Henrich Lobo R, Mattison RJ.

Leuk Lymphoma. 2016 Dec;57(12):2905-2907. Epub 2016 Apr 13. No abstract available.

16.

Centrosome amplification induces high grade features and is prognostic of worse outcomes in breast cancer.

Denu RA, Zasadil LM, Kanugh C, Laffin J, Weaver BA, Burkard ME.

BMC Cancer. 2016 Jan 29;16:47. doi: 10.1186/s12885-016-2083-x.

17.

Loss of SIRT3 Provides Growth Advantage for B Cell Malignancies.

Yu W, Denu RA, Krautkramer KA, Grindle KM, Yang DT, Asimakopoulos F, Hematti P, Denu JM.

J Biol Chem. 2016 Feb 12;291(7):3268-79. doi: 10.1074/jbc.M115.702076. Epub 2015 Dec 2.

18.

Influence of patient, physician, and hospital characteristics on the receipt of guideline-concordant care for inflammatory breast cancer.

Denu RA, Hampton JM, Currey A, Anderson RT, Cress RD, Fleming ST, Lipscomb J, Sabatino SA, Wu XC, Wilson JF, Trentham-Dietz A.

Cancer Epidemiol. 2016 Feb;40:7-14. doi: 10.1016/j.canep.2015.11.003. Epub 2015 Nov 21.

19.

Identification of Selective Lead Compounds for Treatment of High-Ploidy Breast Cancer.

Choudhary A, Zachek B, Lera RF, Zasadil LM, Lasek A, Denu RA, Kim H, Kanugh C, Laffin JJ, Harter JM, Wisinski KB, Saha S, Weaver BA, Burkard ME.

Mol Cancer Ther. 2016 Jan;15(1):48-59. doi: 10.1158/1535-7163.MCT-15-0527. Epub 2015 Nov 19.

20.

Idiopathic CD4 lymphocytopenia with giant cell arteritis and pulmonary mucormycosis.

Denu RA, Rush PS, Ahrens SE, Westergaard RP.

Med Mycol Case Rep. 2014 Nov 4;6:73-5. doi: 10.1016/j.mmcr.2014.10.002. eCollection 2014 Oct.

21.

Macrophages in multiple myeloma: emerging concepts and therapeutic implications.

Asimakopoulos F, Kim J, Denu RA, Hope C, Jensen JL, Ollar SJ, Hebron E, Flanagan C, Callander N, Hematti P.

Leuk Lymphoma. 2013 Oct;54(10):2112-21. doi: 10.3109/10428194.2013.778409. Epub 2013 Apr 11. Review.

22.

Macrophages and mesenchymal stromal cells support survival and proliferation of multiple myeloma cells.

Kim J, Denu RA, Dollar BA, Escalante LE, Kuether JP, Callander NS, Asimakopoulos F, Hematti P.

Br J Haematol. 2012 Aug;158(3):336-46. doi: 10.1111/j.1365-2141.2012.09154.x. Epub 2012 May 15.

23.

Biologic and immunomodulatory properties of mesenchymal stromal cells derived from human pancreatic islets.

Kim J, Breunig MJ, Escalante LE, Bhatia N, Denu RA, Dollar BA, Stein AP, Hanson SE, Naderi N, Radek J, Haughy D, Bloom DD, Assadi-Porter FM, Hematti P.

Cytotherapy. 2012 Sep;14(8):925-35. doi: 10.3109/14653249.2012.684376. Epub 2012 May 9.

Supplemental Content

Support Center